6th Jan 2009 07:00
Cyan Holdings Plc
('Cyan' or 'the Company')
Director / PDMR Shareholdings
As stated in the circular sent to shareholders on 14 August 2008, the Company has awarded interests over Ordinary Shares of the Company to certain directors at 2.5p.
Consistent with this, the remuneration committee of the Company approved the transfer of the existing legal and beneficial interest held by Dr. John Read over 1,000,000 Ordinary shares to the Company's Employee Benefit Trust ('EBT').
The remuneration committee of the Company also approved the transfer of the existing legal and beneficial interest held by Kenn Lamb over 8,200,000 Ordinary shares to the Company's EBT. The existing interest in shares held by Dr John Read and Kenn Lamb entitled them to any value over 22 pence per share.
Following the above transfers Dr John Read and Kenn Lamb were awarded an interest shown in the table below in the ordinary shares of 0.2p each ('Ordinary Shares') of the Company on terms such that the interest will entitle the holders to the value of such Ordinary Shares above 2.5p per Ordinary Share. Additionally the interest will vest absolutely on 2 September 2011.
|
Director |
Interest in Ordinary Shares awarded |
|
Kenn Lamb |
30,000,000 |
|
Dr. John Read |
1,000,000 |
Dr. John Read's direct holding in the Company (including the interest over 1,000,000 Ordinary Shares above) is 4,113,636 Ordinary Shares, representing 0.86 per cent of the issued shared capital of the Company.
Kenn Lamb's direct holding in the Company (including the interest over 30,000,000 Ordinary Shares above) is 35,500,000 Ordinary Shares, representing 7.44 per cent of the issued shared capital of the Company.
Additionally six senior managers employed by Cyan Technology Limited or Cyan Asia Limited have been granted an interest over a total of 5,503,000 Ordinary Shares. on terms such that the interest will entitle the holders to the value of such Ordinary Shares above 2.5p per Ordinary Share. All of these interests over Ordinary Shares will vest on 2 September 2011.
Application has been made for the 27,303,000 new Ordinary Shares to be admitted to trading on the Alternative Investment Market ("AIM") of London Stock Exchange plc. Admission of the new Ordinary Shares is expected to become effective on 7 January 2009.
Following the issue of the new Ordinary Shares, the Company's total issued share capital with voting rights and which is admitted to trading on AIM will consist of 477,129,314 ordinary shares of 0.2p each, with one voting right per share.
Cyan Holdings plc
Kenn Lamb, CEO Tel: +44 (0)1954 234 400 www.cyantechnology.com
Cenkos Securities plc
Stephen Keys/Adrian Hargrave Tel: +44 (0)20 7397 8900 www.cenkos.com
Media enquiries:
Hansard Group
John Bick/Adam Reynolds Tel: +44 (0)20 7245 1100 www.hansardgroup.co.uk
Related Shares:
Cyanconnode